Free Access
Environ. Biosafety Res.
Volume 7, Number 1, January-March 2008
Page(s) 1 - 9
Published online 03 April 2008
  • ACGM (2000) Compendium of Guidance from the UK Health and Safety Commission's Advisory Committee on Genetic Modification. Health & Safety Executive, London [Google Scholar]
  • Allen JE, Salzberg SL (2005) JIGSAW: integration of multiple sources of evidence for gene prediction. Bioinformatics 21: 3596–3603 [CrossRef] [PubMed] [Google Scholar]
  • Barreto V, Marques R, Demengeot J (2001) Early death and severe lymphopenia caused by ubiquitous expression of the Rag1 and Rag2 genes in mice. Eur. J. Immunol. 31: 3763–3772 [CrossRef] [PubMed] [Google Scholar]
  • Berg P, Baltimore D, Brenner S, Roblin III RO, Singer XF (1975) Summary statement of the Asilomar conference on recombinant DNA molecules. Proc. Natl. Acad. Sci. USA 72: 1981–1984 [CrossRef] [Google Scholar]
  • Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463–8471 [PubMed] [Google Scholar]
  • EU (1998) Council Directive 98/81/EC of 26 October 1998, amending Directive 90/219/EEC on the contained use of genetically modified micro-organisms. Off. J. Eur. Comm. 05.12.1998: L 330/13 [Google Scholar]
  • EU (2000) Commission Decision of 27 September 2000 concerning the guidance notes for risk assessment outlined in Annex III of Directive 90/219/EEC an the contained use of genetically modified micro-organisms, 2000/608/EC. Off. J. Eur. Comm. 12.10.2000: L 258/43 [Google Scholar]
  • EU (2001) Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC. Off. J. Eur. Comm. 17.4.2001: L 106/1 [Google Scholar]
  • EU (2002) Commission decision of 24 July 2002 establishing guidance notes supplementing Annex II to Directive 2001/18/EC of the European Parliament and of the Council on the deliberate release into the environment of genetically modified organisms and repealing Council Directive 90/220/EEC, 2002/623/EC. Off. J. Eur. Comm. 30.7.2002: L 200/22 [Google Scholar]
  • Fallaux FJ, Bout A, Van der Velde I, Van den Wollenberg DJ, Hehir KM, Keegan J, Auger C, Cramer SJ, Van Ormondt H, Van der Eb AJ, Valerio D, Hoeben RC (1998) New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. Hum. Gene Ther. 9: 1909–1917 [CrossRef] [PubMed] [Google Scholar]
  • Fry BG (2005) From genome to “venome”: Molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins. Genome Res. 15: 403–420 [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
  • Han JS, Szak ST, Boeke JD (2004) Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 249: 268–274 [CrossRef] [Google Scholar]
  • HSE (2002) Interim guidance on risk assessment of genetically modified micro-organisms eliciting altered immune responses. HSE Newsletter 31, Health & Safety Executive, London [Google Scholar]
  • Hubbard T, Andrews D, Caccamo M, Cameron G, Chen Y, Clamp M, Clarke L, Coates G, Cox T, Cunningham F, Curwen V, Cutts T, Down T, Durbin R, Fernandez-Suarez XM, Gilbert J, Hammond M, Herrero J, Hotz H, Howe K, Iyer V, Jekosch K, Kahari A, Kasprzyk A, Keefe D, Keenan S, Kokocinsci F, London D, Longden I, McVicker G, Melsopp C, Meidl P, Potter S, Proctor G, Rae M, Rios D, Schuster M, Searle S, Severin J, Slater G, Smedley D, Smith J, Spooner W, Stabenau A, Stalker J, Storey R, Trevanion S, Ureta-Vidal A, Vogel J, White S, Woodwark C, Birney E (2005) Ensembl 2005. Nucl. Acids Res. 33: D447–D453 [CrossRef] [Google Scholar]
  • Jackson RJ, Ramsay AJ, Christensen CD, Beaton S, Hall DF, Ramshaw IA (2001) Expression of Mouse Interleukin-4 by a Recombinant Ectromelia Virus Suppresses Cytolytic Lymphocyte Responses and Overcomes Genetic Resistance to Mousepox. J. Virol. 75: 1205–1210 [CrossRef] [PubMed] [Google Scholar]
  • Mazière P, Enright AJ (2007) Prediction of microRNA targets. Drug Discov. Today 12: 452–458 [CrossRef] [PubMed] [Google Scholar]
  • NIH (2002) NIH Guidelines for research involving recombinant DNA molecules. National Institutes of Health, Bethesda [Google Scholar]
  • OECD (1986) Recombinant DNA safety considerations. OECD, Paris [Google Scholar]
  • Stalker J, Gibbins B, Meidl P, Smith J, Spooner W, Hotz H-R, Cox AV (2004) The Ensembl Web Site: Mechanics of a Genome Browser. Genome Res. 14: 951–955 [CrossRef] [PubMed] [Google Scholar]
  • Tanino, M, Debily M-A, Tamura T, Hishiki T, Ogasawara O, Murakawa K, Kawamoto S, Itoh K, Watanabe S, de Souza SJ, Imbeaud S, Graudens E, Eveno E, Hilton P, Sudo Y, Kelso J, Ikeo K, Imanishi T, Gojobori T, Auffray C, Hide W, Okubo K (2005) The Human Anatomic Gene Expression Library (H-ANGEL), the H-Inv integrative display of human gene expression across disparate technologies and platforms. Nucl. Acids Res. 33: D567–D572 [CrossRef] [Google Scholar]
  • Yoo S, McKee BD (2004) Overexpression of Drosophila Rad51 protein (DmRad51) disrupts cell cycle progression and leads to apoptosis. Chromosoma 113: 92–101 [PubMed] [Google Scholar]